- Home
- ADSK vs GSK Comparison
ADSK vs GSK Comparison
Compare ADSK & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSK
- GSK
- Stock Information
- Founded
- ADSK 1982
- GSK 1715
- Country
- ADSK United States
- GSK United Kingdom
- Employees
- ADSK N/A
- GSK N/A
- Industry
- ADSK Computer Software: Prepackaged Software
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- ADSK Technology
- GSK Health Care
- Exchange
- ADSK Nasdaq
- GSK Nasdaq
- Market Cap
- ADSK 61.4B
- GSK 68.2B
- IPO Year
- ADSK N/A
- GSK N/A
- Fundamental
- Price
- ADSK $301.08
- GSK $34.08
- Analyst Decision
- ADSK Buy
- GSK Hold
- Analyst Count
- ADSK 22
- GSK 5
- Target Price
- ADSK $327.86
- GSK $45.50
- AVG Volume (30 Days)
- ADSK 1.2M
- GSK 3.4M
- Earning Date
- ADSK 02-27-2025
- GSK 02-05-2025
- Dividend Yield
- ADSK N/A
- GSK 4.57%
- EPS Growth
- ADSK 18.55
- GSK N/A
- EPS
- ADSK 5.03
- GSK 0.81
- Revenue
- ADSK $5,961,000,000.00
- GSK $41,966,224,352.00
- Revenue This Year
- ADSK $13.61
- GSK $5.80
- Revenue Next Year
- ADSK $12.60
- GSK $3.69
- P/E Ratio
- ADSK $59.86
- GSK $20.40
- Revenue Growth
- ADSK 11.50
- GSK 5.59
- 52 Week Low
- ADSK $195.32
- GSK $31.72
- 52 Week High
- ADSK $326.62
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- ADSK 56.77
- GSK 52.95
- Support Level
- ADSK $288.69
- GSK $33.41
- Resistance Level
- ADSK $302.21
- GSK $33.79
- Average True Range (ATR)
- ADSK 5.47
- GSK 0.46
- MACD
- ADSK 1.33
- GSK 0.12
- Stochastic Oscillator
- ADSK 94.95
- GSK 85.95
About ADSK Autodesk Inc.
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction; product design and manufacturing; and media and entertainment. Autodesk software enables design, modeling, and rendering needs of these industries. The company has over 4 million paid subscribers across 180 countries.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.